Over 12 months, NEUROONE MEDICAL TECHNOLOGIES Corp saw more buying than selling from its insiders — purchases of about $737,000 against sales of $55,000.
Wambeke David J. (Executive Officer) made the biggest buy, worth around $670,000.
Looking at the quarterly pattern: Last full quarter: net buying by insiders. Insiders bought in 3 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Wambeke David J. | Executive Officer | Buy | 33,333 | $2.01 | $67K | SEC |
| Jul 2, 2026 | Christianson Mark | Officer | Sell | 10,000 | $3.18 | $32K | SEC |
| Apr 1, 2026 | Christianson Mark | Officer | Sell | 15,363 | $0.74 | $11K | SEC |
| Mar 16, 2026 | Christianson Mark | Officer | Sell | 100 | $0.80 | $80 | SEC |
| Mar 16, 2026 | Christianson Mark | Officer | Sell | 817 | $0.80 | $654 | SEC |
| Mar 12, 2026 | Christianson Mark | Officer | Sell | 11,611 | $0.80 | $9K | SEC |
| Mar 12, 2026 | Christianson Mark | Officer | Sell | 2,109 | $0.80 | $2K | SEC |
| Mar 3, 2026 | Wambeke David J. | Executive Officer | Buy | 1,000,000 | $0.67 | $670K | SEC |
| Sep 9, 2025 | Christianson Mark | Officer | Sell | 30,000 | $0.74 | $22K | SEC |
| Jun 5, 2025 | Christianson Mark | Officer | Sell | 10,000 | $0.58 | $6K | SEC |
| May 23, 2025 | Christianson Mark | Officer | Sell | 14 | $0.65 | $9 | SEC |
| May 23, 2025 | Christianson Mark | Officer | Sell | 8,967 | $0.62 | $6K | SEC |
| May 21, 2025 | Christianson Mark | Officer | Sell | 3,013 | $0.66 | $2K | SEC |
| May 21, 2025 | Christianson Mark | Officer | Sell | 8,006 | $0.67 | $5K | SEC |
| Apr 7, 2025 | Rosa David A | CEO | Buy | 100,000 | $0.50 | $50K | SEC |
In the last 12 months NEUROONE MEDICAL TECHNOLOGIES Corp insiders made open-market purchases worth about $737,000 and sales worth about $55,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in NMTC was filed on 2026-09-08.
No congressional trades in NMTC were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).